Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-omics and bulk sequencing analyses reveal the roles of prognosis and immune aspects of super-enhancer-induced ZBED2 in pan-cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 May 2026

Ren Jiao, Zhang Na, Zhu Luoyu, Zhang Jinglei, Ma Xiaolin, Zhang Xiuxiu, Li Jiaqiu, Cai Jinwei

Abstract excerpt

BACKGROUND: ZBED2 is a member of the C2H2-zinc-finger BED-type zinc-finger protein family. However, the clinical significance and potential functions of ZBED2 in various cancers have not been systematically explored. METHODS: In this article, we comprehensively analyzed multi-omics and bulk sequencing data to explore the characteristics of ZBED2 in pan-cancer and its potential utility in cancer treatment. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Multiomics

Share to Neoplasms

Share to Prognosis

Share to Transcription Factors

Share to Tumor Microenvironment

Source

Identifiers

PMID: 41288889
DOI: 10.1007/s12094-025-04141-3

Genes

ZBED2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-omics and bulk sequencing analyses reveal the roles of prognosis and immune aspects of super-enhancer-induced ZBED2 in pan-cancer.PMID 41288889Read ↗

Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-CancerSemantic proximity Read ↗

Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor typesSemantic proximity Read ↗

A pan-cancer analysis of the role of WDFY2 in human tumors.Semantic proximity Read ↗

Expression Profile, Prognostic Value, and Therapeutic Potential of NSD2 in Pan-Cancer: A Systematic Analysis Integrating Multi-Omics DataSemantic proximity Read ↗

Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human CancerSemantic proximity Read ↗

Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic MalignanciesSemantic proximity Read ↗

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancerSemantic proximity Read ↗

An overexpression platform reveals the functional diversity of human KRAB-Zinc Finger Proteins in maintaining cellular homeostasisSemantic proximity Read ↗

ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experimentsSemantic proximity Read ↗

Pan-cancer analysis indicates that MYBL2 is associated with the prognosis and immunotherapy of multiple cancers as an oncogeneSemantic proximity Read ↗

Comprehensive pan-cancer in tumors of human with tumor suppressor ZMYND11 geneSemantic proximity Read ↗

Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.